Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DR26FQ94X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,222
Award facts
- Contract value 100% obligated
- $13,221.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,221.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) with an ultimate completion date of November 7, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement executed on November 6, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor serving military and veteran health systems through the DLA's Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for NURTEC ODT, a brand-name migraine medication, reflects AmerisourceBergen's ongoing role in supplying specialized neurological treatments and other critical pharmaceuticals to support Department of Defense healthcare programs globally. The DLA's Pharmaceutical Prime Vendor Global Program is planning Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic supplier for DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQ94X?
SPE2DR26FQ94X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FQ94X worth?
The government has obligated $13,222 on SPE2DR26FQ94X.
Is contract SPE2DR26FQ94X an order under another contract?
Yes. SPE2DR26FQ94X is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FQ94X competed?
The extent of competition for SPE2DR26FQ94X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award